Pacific Biosciences of California, Inc. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Pacific Biosciences of California, Inc. (PACB) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $28.87 million as of 2017-03-31, per its 10-Q filed 2017-05-05.
Discontinued › Notes › Investments › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2017-05-05
- 2017-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $28.87M.
- 2016-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $57.46M.
- 2016-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $76.48M.
- 2016-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $80.03M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2017-03-31 | $28.87M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $57.46M 10-K · filed 2017-03-06 |
| 2016-09-30 | $76.48M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $80.03M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $79.50M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $60.24M 10-K · filed 2016-03-11 |
| 2015-09-30 | $43.65M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $53.79M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $69.35M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $78.11M 10-K · filed 2015-03-12 |
| 2014-09-30 | $69.39M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $80.54M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $71.95M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $76.29M 10-K · filed 2014-03-14 |
| 2013-09-30 | $74.53M 10-Q · filed 2013-11-12 |
| 2012-12-31 | $87.78M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |